Total Payments
$7,001
2024 Payments
$866.15
Companies
33
Transactions
330
Medicare Patients
6,080
Medicare Billing
$996,185
Payment Breakdown by Category
Food & Beverage$6,989 (99.8%)
Education$11.56 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,989 | 329 | 99.8% |
| Education | $11.56 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,113 | 97 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,893 | 112 | $0 (2024) |
| GENZYME CORPORATION | $415.13 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $284.48 | 14 | $0 (2022) |
| Amgen Inc. | $250.06 | 8 | $0 (2024) |
| Philips Electronics North America Corporation | $229.67 | 6 | $0 (2023) |
| Baxter Healthcare | $217.57 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $212.64 | 11 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $155.90 | 4 | $0 (2019) |
| Melinta Therapeutics, Inc. | $129.95 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $866.15 | 41 | GENZYME CORPORATION ($201.99) |
| 2023 | $1,001 | 46 | AstraZeneca Pharmaceuticals LP ($305.12) |
| 2022 | $993.98 | 41 | AstraZeneca Pharmaceuticals LP ($292.15) |
| 2021 | $743.85 | 37 | AstraZeneca Pharmaceuticals LP ($375.21) |
| 2020 | $857.38 | 43 | GlaxoSmithKline, LLC. ($326.96) |
| 2019 | $895.90 | 43 | GlaxoSmithKline, LLC. ($357.94) |
| 2018 | $1,070 | 44 | AstraZeneca Pharmaceuticals LP ($406.88) |
| 2017 | $572.57 | 35 | GlaxoSmithKline, LLC. ($296.37) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $146.95 | General |
| Category: Immunology | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Airway Clearance Device | ||||||
| 10/31/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Airway Clearance Device | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Surgical Care | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Airway Clearance Device | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Immunology | ||||||
| 08/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Airway Clearance Device | ||||||
| 08/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,164 | 2,152 | $406,948 | $190,563 |
| 2022 | 15 | 1,454 | 2,729 | $271,370 | $201,802 |
| 2021 | 16 | 1,447 | 2,900 | $343,939 | $271,224 |
| 2020 | 19 | 2,015 | 3,880 | $425,977 | $332,596 |
Total Patients
6,080
Total Services
11,661
Medicare Billing
$996,185
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 1,049 | $192,621 | $96,181 | 49.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 63 | 299 | $111,150 | $49,172 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $26,886 | $13,685 | 50.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 96 | $19,603 | $8,705 | 44.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 46 | $17,720 | $6,160 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 71 | $13,530 | $4,782 | 35.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 62 | $6,974 | $3,686 | 52.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 69 | 71 | $2,776 | $1,862 | 67.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,990 | $1,241 | 31.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,679 | $1,118 | 30.4% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 20 | 39 | $1,170 | $1,040 | 88.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 29 | 29 | $1,132 | $728.67 | 64.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 69 | 69 | $1,599 | $607.20 | 38.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 69 | 69 | $1,389 | $450.12 | 32.4% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 24 | 27 | $486.00 | $323.25 | 66.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 43 | 43 | $1,096 | $315.60 | 28.8% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 25 | 25 | $611.00 | $264.96 | 43.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 23 | $536.00 | $242.07 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 493 | 1,181 | $153,365 | $112,221 | 73.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 63 | 247 | $53,375 | $42,819 | 80.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 123 | 123 | $20,410 | $15,761 | 77.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 149 | $10,728 | $8,293 | 77.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 41 | $8,075 | $6,283 | 77.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 52 | $5,304 | $4,152 | 78.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 121 | 124 | $4,943 | $3,474 | 70.3% |
About Dr. Juan Llompart, MD
Dr. Juan Llompart, MD is a Pulmonary Disease healthcare provider based in Victoria, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790893576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Llompart, MD has received a total of $7,001 in payments from pharmaceutical and medical device companies, with $866.15 received in 2024. These payments were reported across 330 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,989).
As a Medicare-enrolled provider, Llompart has provided services to 6,080 Medicare beneficiaries, totaling 11,661 services with total Medicare billing of $996,185. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Victoria, TX
- Active Since 08/29/2006
- Last Updated 08/01/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1790893576
Products in Payments
- NUCALA (Biological) $831.11
- TRELEGY ELLIPTA (Drug) $695.50
- TEZSPIRE (Biological) $673.68
- DUPIXENT (Biological) $613.97
- FASENRA (Drug) $548.37
- SYMBICORT (Drug) $425.75
- FASENRA (Biological) $356.50
- Hillrom - Vest System Model 105 Home Care (Device) $167.19
- BREO (Drug) $145.71
- STIOLTO RESPIMAT (Drug) $144.45
- ZERBAXA (Drug) $141.25
- Vabomere (Drug) $129.95
- (7999) SRC Und (Device) $129.76
- Arikayce (Drug) $120.67
- ANORO (Drug) $116.91
- FLOWTRIEVER CATHETER, S (Device) $115.05
- Veltassa (Drug) $94.16
- OFEV (Drug) $79.44
- (8874) inCourage (Device) $73.96
- Yupelri (Drug) $70.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.